The DOI matches its Crossref record; 171 of the 171 references it cites were found in a registry or an index.
Administration, distribution, metabolism and elimination of polymer therapeutics
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Boussif, O., Lezoualc'h, F., Zanta, M. A., Mergny, M. D., Scherman, D., Demeneix, B., & Behr, J. P. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.16.7297 · Cited by 6,247
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
Biodegradable polymers as biomaterials
Nair, L. S., & Laurencin, C. T. (2007) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2007.05.017 · Cited by 4,416
Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses
Kato, H., Takeuchi, O., Sato, S., Yoneyama, M., Yamamoto, M., Matsui, K., Uematsu, S., Jung, A., Kawai, T., Ishii, K. J., et al. (2006) · Nature · doi:10.1038/nature04734 · Cited by 3,888
Factors affecting the clearance and biodistribution of polymeric nanoparticles
Alexis, F., Pridgen, E., Molnar, L. K., & Farokhzad, O. C. (2008) · Molecular Pharmaceutics · doi:10.1021/mp800051m · Cited by 3,699
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles
OWENSIII, D., & PEPPAS, N. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.10.010 · Cited by 3,637
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Overexpression of a Transporter Gene in a Multidrug-Resistant Human Lung Cancer Cell Line
Cole, S. P. C., Bhardwaj, G., Gerlach, J. H., Mackie, J. E., Grant, C. E., Almquist, K. C., Stewart, A. J., Kurz, E. U., Duncan, A. M. V., & Deeley, R. G. (1992) · Science · doi:10.1126/science.1360704 · Cited by 3,037
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Shape effects of filaments versus spherical particles in flow and drug delivery
Geng, Y., Dalhaimer, P., Cai, S., Tsai, R., Tewari, M., Minko, T., & Discher, D. E. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.70 · Cited by 2,565
Production of large amounts of hydrogen peroxide by human tumor cells.
Szatrowski, T. P., & Nathan, C. (1991) · PubMed · Cited by 2,526
Expression profiling reveals off-target gene regulation by RNAi
Jackson, A. L., Bartz, S. R., Schelter, J., Kobayashi, S. V., Burchard, J., Mao, M., Li, B., Cavet, G., & Linsley, P. S. (2003) · Nature Biotechnology · doi:10.1038/nbt831 · Cited by 2,370
A multidrug resistance transporter from human MCF-7 breast cancer cells
Doyle, L. A., Yang, W., Abruzzo, L. V., Krogmann, T., Gao, Y., Rishi, A. K., & Ross, D. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15665 · Cited by 2,322
Angiogenesis: an organizing principle for drug discovery?
Folkman, J. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2115 · Cited by 2,246
Molecular mechanism and physiological functions of clathrin-mediated endocytosis
McMahon, H. T., & Boucrot, E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3151 · Cited by 2,223
Pegaptanib, a targeted anti-VEGF aptamer for ocular vascular disease
Ng, E. W. M., Shima, D. T., Calias, P., Cunningham, E. T., Guyer, D. R., & Adamis, A. P. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1955 · Cited by 1,588
ENDOCYTOSIS AND MOLECULAR SORTING
Mellman, I. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.575 · Cited by 1,533
Mediating Tumor Targeting Efficiency of Nanoparticles Through Design
Perrault, S. D., Walkey, C., Jennings, T., Fischer, H. C., & Chan, W. C. W. (2009) · Nano Letters · doi:10.1021/nl900031y · Cited by 1,513
Nanoparticles as potential oral delivery systems of proteins and vaccines: A mechanistic approach
des Rieux, A., Fievez, V., Garinot, M., Schneider, Y.-J., & Préat, V. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.08.013 · Cited by 1,305
multifunctional enzymes in cancer
Mohamed, M. M., & Sloane, B. F. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1949 · Cited by 1,265
Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA
Judge, A. D., Sood, V., Shaw, J. R., Fang, D., McClintock, K., & MacLachlan, I. (2005) · Nature Biotechnology · doi:10.1038/nbt1081 · Cited by 1,250
Matrix metalloproteinases: effectors of development and normal physiology
Vu, T. H., & Werb, Z. (2000) · Genes & Development · doi:10.1101/gad.815400 · Cited by 1,235
Polymer Therapeutics: Concepts and Applications
Haag, R., & Kratz, F. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200502113 · Cited by 1,115
Regulation of matrix biology by matrix metalloproteinases
Mott, J. D., & Werb, Z. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.07.010 · Cited by 1,104 · cited 1×
“Though MMP were discovered as ECM degrading enzymes, an emerging view is that matrix degradation is not the only (or even primary) function of these enzymes, and their activity has been extended to cell growth, signaling, migration, differentiation, and apoptosis [107-109].”
BackgroundStructure and properties of pharmacologically active polymers
Ringsdorf, H. (1975) · Journal of Polymer Science: Polymer Symposia · doi:10.1002/polc.5070510111 · Cited by 1,094
Chloride Accumulation and Swelling in Endosomes Enhances DNA Transfer by Polyamine-DNA Polyplexes
Sonawane, N. D., Szoka, F. C., & Verkman, A. S. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308643200 · Cited by 1,081
Targeted Drug Delivery via the Transferrin Receptor-Mediated Endocytosis Pathway
Qian, Z. M., Li, H., Sun, H., & Ho, K. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.4.561 · Cited by 1,019
Widespread siRNA “off-target” transcript silencing mediated by seed region sequence complementarity
Jackson, A. L., Burchard, J., Schelter, J., Chau, B. N., Cleary, M., Lim, L., & Linsley, P. S. (2006) · RNA · doi:10.1261/rna.25706 · Cited by 956
The proton sponge: a trick to enter cells the viruses did not exploit
Behr, J.-P. (1997) · CHIMIA · doi:10.2533/chimia.1997.34 · Cited by 933 · cited 2×
“Behr in 1995 [134], is that endosomal escape occurs by the “proton sponge” effect [133-136].”
BackgroundsiRNAs: applications in functional genomics and potential as therapeutics
Dorsett, Y., & Tuschl, T. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1345 · Cited by 909
Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.
Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 859
Endocytosis by random initiation and stabilization of clathrin-coated pits
Ehrlich, M., Boll, W., van Oijen, A., Hariharan, R., Chandran, K., Nibert, M. L., & Kirchhausen, T. (2004) · Cell · doi:10.1016/j.cell.2004.08.017 · Cited by 843
Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases
Hu, J., Van den Steen, P. E., Sang, Q.-X. A., & Opdenakker, G. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2308 · Cited by 795
Position-specific chemical modification of siRNAs reduces “off-target” transcript silencing
Jackson, A. L., Burchard, J., Leake, D., Reynolds, A., Schelter, J., Guo, J., Johnson, J. M., Lim, L., Karpilow, J., Nichols, K., et al. (2006) · RNA · doi:10.1261/rna.30706 · Cited by 789
Yamaoka, T., Tabata, Y., & Ikada, Y. (1994) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600830432 · Cited by 748
Armstrong, J. K., Hempel, G., Koling, S., Chan, L. S., Fisher, T., Meiselman, H. J., & Garratty, G. (2007) · Cancer · doi:10.1002/cncr.22739 · Cited by 699
Vasey, P. A., Kaye, S. B., Morrison, R. A., Twelves, C. J., Wilson, P., Duncan, R., Thomson, A. H., Murray, L. S., Hilditch, T. E., Murray, T., et al. (1999) · PubMed · Cited by 689
PEGylation of therapeutic proteins
Jevševar, S., Kunstelj, M., & Porekar, V. G. (2010) · Biotechnology Journal · doi:10.1002/biot.200900218 · Cited by 681
Variants of the cell recognition site of fibronectin that retain attachment-promoting activity.
Pierschbacher, M. D., & Ruoslahti, E. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.19.5985 · Cited by 681
Chitosan Nanoparticles: A Promising System in Novel Drug Delivery
Nagpal, K., Singh, S. K., & Mishra, D. N. (2010) · CHEMICAL & PHARMACEUTICAL BULLETIN · doi:10.1248/cpb.58.1423 · Cited by 660
Polymer–drug conjugates: Progress in polymeric prodrugs
Khandare, J., & Minko, T. (2006) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2005.09.004 · Cited by 639
The Activity of Collagenase-1 Is Required for Keratinocyte Migration on a Type I Collagen Matrix
Pilcher, B. K., Dumin, J. A., Sudbeck, B. D., Krane, S. M., Welgus, H. G., & Parks, W. C. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.6.1445 · Cited by 612
Keystone, E., Heijde, D. V. D., Mason, D., Landewé, R., Vollenhoven, R. V., Combe, B., Emery, P., Strand, V., Mease, P., Desai, C., et al. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23964 · Cited by 576
HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action
Kopecek, J. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00075-8 · Cited by 562
(1998) · Molecular Reproduction and Development · doi:10.1002/(sici)1098-2795(199812)51:4<477::aid-mrd17>3.0.co;2-w · Cited by 548
Therapeutic strategies by modulating oxygen stress in cancer and inflammation
Fang, J., Seki, T., & Maeda, H. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.02.005 · Cited by 544
MEROPS: the peptidase database
Rawlings, N. D., Morton, F. R., Kok, C. Y., Kong, J., & Barrett, A. J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm954 · Cited by 520
Pegylated interferon-α2b: Pharmacokinetics, pharmacodynamics, safety, and preliminary efficacy data
Glue, P. (2000) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2000.110973 · Cited by 504
Polymeric anticancer drugs with pH-controlled activation
Ulbrich, K. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.040 · Cited by 494
Prodrug Strategies in Anticancer Chemotherapy
Kratz, F., Müller, I. A., Ryppa, C., & Warnecke, A. (2008) · ChemMedChem · doi:10.1002/cmdc.200700159 · Cited by 486
Gabizon, A., & Martin, F. (1997) · Drugs · doi:10.2165/00003495-199700544-00005 · Cited by 478
PEG conjugates in clinical development or use as anticancer agents: An overview
Pasut, G., & Veronese, F. M. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.02.010 · Cited by 457
Seymour, L. W., Duncan, R., Strohalm, J., & Kopeček, J. (1987) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820211106 · Cited by 436
Hepatic Drug Targeting: Phase I Evaluation of Polymer-Bound Doxorubicin
Seymour, L. W., Ferry, D. R., Anderson, D., Hesslewood, S., Julyan, P. J., Poyner, R., Doran, J., Young, A., Burtles, S. S., & Kerr, D. J. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.6.1668 · Cited by 435
Dextrans for targeted and sustained delivery of therapeutic and imaging agents
Mehvar, R. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(00)00302-3 · Cited by 434
Cysteine cathepsins: Cellular roadmap to different functions
Brix, K., Dunkhorst, A., Mayer, K., & Jordans, S. (2008) · Biochimie · doi:10.1016/j.biochi.2007.07.024 · Cited by 428
Barz, M., Luxenhofer, R., Zentel, R., & Vicent, M. J. (2011) · Polymer Chemistry · doi:10.1039/c0py00406e · Cited by 418
Polymeric micelles for oral drug delivery
Gaucher, G., Satturwar, P., Jones, M.-C., Furtos, A., & Leroux, J.-C. (2010) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2010.06.007 · Cited by 389
Brault, L., Gasser, C., Bracher, F., Huber, K., Knapp, S., & Schwaller, J. (2010) · Haematologica · doi:10.3324/haematol.2009.017079 · Cited by 368
Cathepsin cysteine proteases in cardiovascular disease
Lutgens, S. P. M., Cleutjens, K. B. J. M., Daemen, M. J. A. P., & Heeneman, S. (2007) · The FASEB Journal · doi:10.1096/fj.06-7924com · Cited by 351
Ganson, N. J., Kelly, S. J., Scarlett, E., Sundy, J. S., & Hershfield, M. S. (2005) · Arthritis Research & Therapy · doi:10.1186/ar1861 · Cited by 350
In vivo imaging of proteolytic enzyme activity using a novel molecular reporter.
Tung, C., Mahmood, U., Bredow, S., & Weissleder, R. (2000) · PubMed · Cited by 345
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
Satchi-Fainaro, R., Puder, M., Davies, J. W., Tran, H. T., Sampson, D. A., Greene, A. K., Corfas, G., & Folkman, J. (2004) · Nature Medicine · doi:10.1038/nm1002 · Cited by 345
Self-citationSeymour, L. W., Miyamoto, Y., Maeda, H., Brereton, M., Strohalm, J., Ulbrich, K., & Duncan, R. (1995) · European Journal of Cancer · doi:10.1016/0959-8049(94)00514-6 · Cited by 337
PEGylated Proteins: Evaluation of Their Safety in the Absence of Definitive Metabolism Studies
Webster, R., Didier, E., Harris, P., Siegel, N., Stadler, J., Tilbury, L., & Smith, D. (2007) · Drug Metabolism and Disposition · doi:10.1124/dmd.106.012419 · Cited by 337
Liu, C., Sun, C., Huang, H., Janda, K. D., & Edgington, T. S. (2003) · PubMed · Cited by 334
Polymer conjugates with anticancer activity
Putnam, D., & Kopeček, J. (1995) · Advances in Polymer Science · doi:10.1007/3540587888_14 · Cited by 315
Cysteine cathepsin proteases as pharmacological targets in cancer
Palermo, C., & Joyce, J. A. (2008) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.10.011 · Cited by 310
Gaspar, R., & Duncan, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.003 · Cited by 304
Seymour (2009) · International Journal of Oncology · doi:10.3892/ijo_00000293 · Cited by 304
Intracellular targeting of polymer-bound drugs for cancer chemotherapy
NORI, A., & KOPECEK, J. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2004.10.006 · Cited by 303
Hypoxia signalling controls metabolic demand
Brahimi-Horn, M. C., Chiche, J., & Pouysségur, J. (2007) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2007.02.003 · Cited by 298
Gabizón, A., & Martin, F. J. (1997) · Drugs · Cited by 293
Overcoming the Innate Immune Response to Small Interfering RNA
Judge, A., & MacLachlan, I. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.179 · Cited by 284
Veronese, F. M., Schiavon, O., Pasut, G., Mendichi, R., Andersson, L., Tsirk, A., Ford, J., Wu, G., Kneller, S., Davies, J., et al. (2005) · Bioconjugate Chemistry · doi:10.1021/bc040241m · Cited by 282
Delivery of peptide and protein drugs over the blood–brain barrier
Brasnjevic, I., Steinbusch, H. W. M., Schmitz, C., & Martinez-Martinez, P. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2008.12.002 · Cited by 279
Bendele, A. M., Seely, J., Richey, C., Sennello, G., & Shopp, G. M. (1998) · Toxicological Sciences · doi:10.1006/toxs.1997.2396 · Cited by 279
Receptor-mediated and enzyme-dependent targeting of cytotoxic anticancer drugs
Dubowchik, G. M., & Walker, M. A. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00018-2 · Cited by 277
Noninvasive optical imaging of apoptosis by caspase-targeted activity-based probes
Edgington, L. E., Berger, A. B., Blum, G., Albrow, V. E., Paulick, M. G., Lineberry, N., & Bogyo, M. (2009) · Nature Medicine · doi:10.1038/nm.1938 · Cited by 276
Matrilysin expression and function in airway epithelium.
Dunsmore, S. E., Saarialho-Kere, U. K., Roby, J. D., Wilson, C. L., Matrisian, L. M., Welgus, H. G., & Parks, W. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1516 · Cited by 270
Metalloproteases and inhibitors in arthritic diseases
Martel-Pelletier, J., Welsch, D. J., & Pelletier, J.-P. (2001) · Best Practice & Research Clinical Rheumatology · doi:10.1053/berh.2001.0195 · Cited by 270
Endothelial Cell Adhesion Molecules and Cancer Progression
Kobayashi, H., Boelte, K., & Lin, P. C. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707779941032 · Cited by 244
Minko, T., Kopečková, P., Pozharov, V., & Kopeček, J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00009-1 · Cited by 243
PEGylated Protein Drugs: Basic Science and Clinical Applications
(2009) · doi:10.1007/978-3-7643-8679-5 · Cited by 241
Saad, M., Garbuzenko, O. B., Ber, E., Chandna, P., Khandare, J. J., Pozharov, V. P., & Minko, T. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.05.024 · Cited by 238
Wiwattanapatapee, R., Carreño-Gómez, B., Malik, N., & Duncan, R. (2000) · Pharmaceutical Research · doi:10.1023/a:1007587523543 · Cited by 234
Duncan, R., & Vicent, M. J. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.12.005 · Cited by 230
Richter, A. W., & Åkerblom, E. (1984) · International Archives of Allergy and Immunology · doi:10.1159/000233512 · Cited by 229
Disposition Characteristics of Macromolecules in Tumor-Bearing Mice
Takakura, Y., Fujita, T., Hashida, M., & Sezaki, H. (1990) · Pharmaceutical Research · doi:10.1023/a:1015807119753 · Cited by 221
Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate
Omelyanenko, V, Kopečková, P., Gentry, C., & Kopeček, J. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00235-6 · Cited by 216
Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles
Panagi, Z., Beletsi, A., Evangelatos, G., Livaniou, E., Ithakissios, D. S., & Avgoustakis, K. (2001) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(01)00676-7 · Cited by 215
Duncan, R., Cable, H. C., Lloyd, J. B., Rejmanová, P., & Kopeček, J. (1983) · Die Makromolekulare Chemie · doi:10.1002/macp.1983.021841005 · Cited by 193
Goel, N., & Stephens, S. (2010) · mAbs · doi:10.4161/mabs.2.2.11271 · Cited by 188
Webster, R., Elliott, V., Park, B. K., Walker, D., Hankin, M., & Taupin, P. (2009) · PEGylated Protein Drugs: Basic Science and Clinical Applications · doi:10.1007/978-3-7643-8679-5_8 · Cited by 187
Drug-Polymer Conjugates Containing Acid-Cleavable Bonds
Kratz, F., Beyer, U., & Schutte, M. T. (1999) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v16.i3.10 · Cited by 181
Radioiodination of Alginate via Covalently-Bound Tyrosinamide Allows Monitoring of its Fate In Vivo
Al-Shamkhani, A., & Duncan, R. (1995) · Journal of Bioactive and Compatible Polymers · doi:10.1177/088391159501000102 · Cited by 180
Miller, K., Erez, R., Segal, E., Shabat, D., & Satchi‐Fainaro, R. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200805133 · Cited by 179
Self-citationGao, W., Liu, W., Mackay, J. A., Zalutsky, M. R., Toone, E. J., & Chilkoti, A. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0904378106 · Cited by 176
Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin
Satchi-Fainaro, R., Mamluk, R., Wang, L., Short, S. M., Nagy, J. A., Feng, D., Dvorak, A. M., Dvorak, H. F., Puder, M., Mukhopadhyay, D., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.02.007 · Cited by 173
Self-citationMolecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides
Dharap, S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00209-8 · Cited by 172
Bohrer, M. P., Deen, W. M., Robertson, C. R., Troy, J. L., & Brenner, B. M. (1979) · The Journal of general physiology · doi:10.1085/jgp.74.5.583 · Cited by 166
Wang, D., Miller, S. C., Liu, X., Anderson, B., Wang, X., & Goldring, S. R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2106 · Cited by 159
Matrix metalloproteases: Underutilized targets for drug delivery
Vartak, D. G., & Gemeinhart, R. A. (2007) · Journal of drug targeting · doi:10.1080/10611860600968967 · Cited by 159
Conjugated Chitosan as a Novel Platform for Oral Delivery of Paclitaxel
Lee, E., Lee, J., Lee, I., Yu, M., Kim, H., Chae, S. Y., & Jon, S. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800767c · Cited by 157
Gao, W., Liu, W., Christensen, T., Zalutsky, M. R., & Chilkoti, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006044107 · Cited by 153
Phase I clinical and pharmacokinetic trial of dextran conjugated doxorubicin (AD-70, DOX-OXD)
Danhauser-riedl, S., Hausmann, E., Schick, H.-D., Bender, R., Dietzfelbinger, H., Rastetter, J., & Hanauske, A.-R. (1993) · Investigational New Drugs · doi:10.1007/bf00874153 · Cited by 152
Carrier-based strategies for targeting protein and peptide drugs to the lungs
Cryan, S. (2005) · The AAPS Journal · doi:10.1208/aapsj070104 · Cited by 149
10 years of patch testing with the (meth)acrylate series
Kanerva, L., Jolanki, R., & Estlander, T. (1997) · Contact Dermatitis · doi:10.1111/j.1600-0536.1997.tb02460.x · Cited by 149
Polymer Therapeutics for Cancer: Current Status and Future Challenges
Satchi‐Fainaro, R., Duncan, R., & Barnés, C. M. (2005) · Springer eBooks · doi:10.1007/12_024 · Cited by 146
Self-citationIn vivo antitumor effects of chitosan-conjugated docetaxel after oral administration
Lee, E., Kim, H., Lee, I., & Jon, S. (2009) · Journal of Controlled Release · doi:10.1016/j.jconrel.2009.08.014 · Cited by 144
Schluep, T., Cheng, J., Khin, K. T., & Davis, M. E. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-005-0091-7 · Cited by 142
Luo, K., Yang, J., Kopečková, P., & Kopec̆ek, J. (2011) · Macromolecules · doi:10.1021/ma102574e · Cited by 140
MMPs and TIMPs-An Historical Perspective
Woessner, J. F. (2002) · Molecular Biotechnology · doi:10.1385/mb:22:1:033 · Cited by 139
Lammers, T., Kühnlein, R., Kissel, M., Šubr, V., Etrych, T., Pola, R., Pechar, M., Ulbrich, K., Storm, G., Huber, P. E., et al. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.09.010 · Cited by 131
Fate of Water‐Soluble Polymers Administered via Different Routes
Yamaoka, T., Tabata, Y., & Ikada, Y. (1995) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600840316 · Cited by 130
Antibody-targeted Polymer–doxorubicin Conjugates with pH-controlled Activation
Ulbrich, K., Etrych, T., Chytil, P., Jelínková, M., & Řı́hová, B. (2004) · Journal of drug targeting · doi:10.1080/10611860400011869 · Cited by 128
Chipman, S. D., Oldham, F. B., Pezzoni, G., & Singer, J. W. (2006) · International Journal of Nanomedicine · doi:10.2147/nano.2006.1.4.375 · Cited by 125
Conover, C. D., Greenwald, R. B., Pendri, A., Gilbert, C. W., & Shum, K. L. (1998) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050837 · Cited by 122
Targeting antibodies to the cytoplasm
Marschall, A. L. J., Frenzel, A., Schirrmann, T., Schüngel, M., & Dübel, S. (2011) · mAbs · doi:10.4161/mabs.3.1.14110 · Cited by 120
RNA interference and innate immunity
Sioud, M. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.006 · Cited by 116
Targeting Angiogenesis-Dependent Calcified Neoplasms Using Combined Polymer Therapeutics
Segal, E., Pan, H., Ofek, P., Udagawa, T., Kopečková, P., Kopec̆ek, J., & Satchi‐Fainaro, R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005233 · Cited by 116
Self-citationTargeted delivery of therapeutics to endothelium
Simone, E. A., Ding, B., & Muzykantov, V. R. (2008) · Cell and Tissue Research · doi:10.1007/s00441-008-0676-7 · Cited by 116
Yang, J., Luo, K., Pan, H., Kopečková, P., & Kopec̆ek, J. (2010) · Reactive and Functional Polymers · doi:10.1016/j.reactfunctpolym.2010.10.005 · Cited by 114
Macromolecule transport across glomerular capillaries: Application of pore theory
Deen, W. M., Bohrer, M. P., & Brenner, B. M. (1979) · Kidney International · doi:10.1038/ki.1979.138 · Cited by 112
Magnusson, J. P., Bersani, S., Salmaso, S., Alexander, C., & Caliceti, P. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900468v · Cited by 109
Yurkovetskiy, A., & Fram, R. J. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.01.007 · Cited by 100
Pan, H., Yang, J., Kopečková, P., & Kopec̆ek, J. (2010) · Biomacromolecules · doi:10.1021/bm101254e · Cited by 100
Immunological Risk of Injectable Drug Delivery Systems
Jiskoot, W., van Schie, R. M., Carstens, M. G., & Schellekens, H. (2009) · Pharmaceutical Research · doi:10.1007/s11095-009-9855-9 · Cited by 100
Polymers for pro- and anti-angiogenic therapy
Fischbach, C., & Mooney, D. J. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2006.12.029 · Cited by 98
Minko, T., Kopečková, P., & Kopec̆ek, J. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00186-2 · Cited by 97
Activatable Molecular Probes for Cancer Imaging
Lee, S., Xie, J., & Chen, X. S. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610791384270 · Cited by 95
Targeting the neural cell adhesion molecule in cancer
Jensen, M., & Berthold, F. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.09.004 · Cited by 91
Polymer–Drug Conjugates for Novel Molecular Targets
Sanchis, J., Canal, F., Lucas-Domínguez, R., & Vicent, M. J. (2010) · Nanomedicine · doi:10.2217/nnm.10.71 · Cited by 89
Anticancer carrier-linked prodrugs in clinical trials
Kratz, F., Ajaj, K. A., & Warnecke, A. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.1037 · Cited by 88
Olsen, C. A., & Ghadiri, M. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900850t · Cited by 86
Anti-vascular tumor therapy: recent advances, pitfalls and clinical perspectives
Eichhorn, M., Strieth, S., & Dellian, M. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.03.001 · Cited by 84
Design and development of polymer conjugates as anti-angiogenic agents
Segal, E., & Satchi‐Fainaro, R. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.06.005 · Cited by 78
Self-citationDesign of oral insulin delivery systems
Wong, T. W. (2009) · Journal of drug targeting · doi:10.3109/10611860903302815 · Cited by 76
Malignant Progression and Blockade of Angiogenesis in a Murine Transgenic Model of Neuroblastoma
Chesler, L., Goldenberg, D., Seales, I. T., Satchi‐Fainaro, R., Grimmer, M., Collins, R., Struett, C., Nguyen, K. N., Kim, G., Tihan, T., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1316 · Cited by 73
Self-citationKovář, M., Strohalm, J., Etrych, T., Ulbrich, K., & Řı́hová, B. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010063m · Cited by 70
Novel opioid antagonists for opioid-induced bowel dysfunction
Diego, L., Atayee, R. S., Helmons, P., et al. (2011) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2011.592830 · Cited by 70
Drug Delivery in Oncology: From Basic Research to Cancer Therapy
Kratz, F., Senter, P., & Steinhagen, H. (2011) · Wiley eBooks · doi:10.1002/9783527634057 · Cited by 69
Knorr, V., Ogris, M., & Wagner, E. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9700-6 · Cited by 68
Kiang, J. G., & Tsen, K. (2006) · PubMed · Cited by 66
Immunomodulating activities of soluble synthetic polymer-bound drugs
Říhová, B. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00043-1 · Cited by 64
A novel approach to oral delivery of insulin by conjugating with low molecular weight chitosan
Lee, E., Lee, J., & Jon, S. (2010) · Bioconjugate Chemistry · doi:10.1021/bc100093v · Cited by 63
Barz, M., Canal, F., Koynov, K., Zentel, R., & Vicent, M. J. (2010) · Biomacromolecules · doi:10.1021/bm100338x · Cited by 62
Biopharmaceutical Properties of Uricase Conjugated to Neutral and Amphiphilic Polymers
Caliceti, P., Schiavon, O., & Veronese, F. M. (1999) · Bioconjugate Chemistry · doi:10.1021/bc980155k · Cited by 62
New strategies for polymer development in pharmaceutical science — a short review
Godwin, A., Bolina, K., Clochard, M.-C., Dinand, E., Rankin, S., Simic, S., & Brocchini, S. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011776612 · Cited by 60
Antigen−Adjuvant Nanoconjugates for Nasal Vaccination: An Improvement over the Use of Nanoparticles?
Slütter, B., Bal, S. M., Que, I., Kaijzel, E. L., Löwik, C. W. G. M., Bouwstra, J. A., & Jiskoot, W. (2010) · Molecular Pharmaceutics · doi:10.1021/mp100210g · Cited by 59
Wu, S.-M., Huang, Y.-H., Yeh, C.-H., Tsai, M.-M., Liao, C., Cheng, W.-L., Chen, W. J., & Lin, K.-H. (2011) · Oncogene · doi:10.1038/onc.2010.585 · Cited by 57
Albain, K. S., Belani, C. P., Bonomi, P., O'Byrne, K. J., Schiller, J. H., & Socinski, M. A. (2006) · Clinical Lung Cancer · doi:10.3816/clc.2006.n.027 · Cited by 57
The Structure and Function of Histone Deacetylases: The Target for Anti-cancer Therapy
Zhang, Y., Fang, H., Jiao, J., & Xu, W. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786242796 · Cited by 53
Comparison of allergic reactions to pegasparaginase given intravenously versus intramuscularly
Pidaparti, M., & Bostrom, B. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.23380 · Cited by 47
Caspase 7: increased expression and activation after traumatic brain injury in rats
Larner, S. F., McKinsey, D. M., Hayes, R. L., & Wang, K. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03172.x · Cited by 47
Bonomi, P. (2007) · Expert Review of Anticancer Therapy · doi:10.1586/14737140.7.4.415 · Cited by 46
Antibodies Neutralizing Peginterferon Alfa during Retreatment of Hepatitis C
van der Eijk, A. A., Vrolijk, J. M., & Haagmans, B. L. (2006) · New England Journal of Medicine · doi:10.1056/nejmc052880 · Cited by 45
Beyond oncology — Application of HPMA copolymers in non-cancerous diseases☆
Liu, X.-M., Miller, S. C., & Wang, D. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.006 · Cited by 41
Soluble, crosslinked N-(2-hydroxypropyl)methacrylamide copolymers as potential drug carriers
Cartlidge, S. A., Duncan, R., Lloyd, J. B., Rejmanová, P., & Kopeček, J. (1986) · Journal of Controlled Release · doi:10.1016/0168-3659(86)90064-7 · Cited by 40
Barz, M., Wolf, F. K., Canal, F., Koynov, K., Vicent, M. J., Frey, H., & Zentel, R. (2010) · Macromolecular Rapid Communications · doi:10.1002/marc.201000090 · Cited by 37
Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
Li, S., & Huang, L. (2008) · PubMed · Cited by 33
Nanoparticulate carriers (NPC) for oral pharmaceutics and nutraceutics
Lopes, C. M., Lopes, C. M., Martins‐Lopes, P., Souto, E. B., & Souto, E. B. (2010) · Die Pharmazie · doi:10.31083/ph.2010.9338 · Cited by 23
Design of Polymer‐Drug Conjugates
Kopec̆ek, J., & Kopečková, P. (2011) · Wiley eBooks · doi:10.1002/9783527634057.ch17 · Cited by 15
Pathophysiological and Vascular Characteristics of Solid Tumors in Relation to Drug Delivery
Vaupel, P. W. (2011) · Wiley eBooks · doi:10.1002/9783527634057.ch2 · Cited by 6
Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus
Gergely, P., Grossman, C., Niland, B., Puskas, F., Neupane, H., Allam, F., Banki, K., Phillips, P. E., & Perl, A. (2002) · Arthritis & Rheumatism · doi:10.1002/1529-0131(200201)46:1 · Cited by 5
Recent Progress in Polymer Therapeutics as Nanomedicines
Peer, D. (2012) · doi:10.1201/b11620-6 · Cited by 4
Ligand‐Assisted Vascular Targeting of Polymer Therapeutics
Eldar‐Boock, A., Polyak, D., & Satchi‐Fainaro, R. (2011) · Wiley eBooks · doi:10.1002/9783527634057.ch20 · Cited by 3
Self-citation
Cited by
Larrañeta, E., Lutton, R. E. M., Woolfson, A. D., & Donnelly, R. F. (2016) · Materials Science and Engineering: R: Reports · doi:10.1016/j.mser.2016.03.001 · Cited by 964
Mesoporous Silica Nanoparticles for Drug Delivery
Manzano, M., & Vallet‐Regí, M. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201902634 · Cited by 939
Albumin-based drug delivery: harnessing nature to cure disease
Larsen, M. T., Kuhlmann, M., Hvam, M. L., & Howard, K. A. (2016) · Molecular and Cellular Therapies · doi:10.1186/s40591-016-0048-8 · Cited by 683
Current hurdles to the translation of nanomedicines from bench to the clinic
Đorđević, S., Gonzalez, M. M., Conejos-Sánchez, I., Carreira, B., Pozzi, S., Acúrcio, R. C., Satchi-Fainaro, R., Florindo, H. F., & Vicent, M. J. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01024-2 · Cited by 657
Self-citationChitosan oligosaccharide (COS): An overview
Naveed, M., Phil, L., Sohail, M., Hasnat, M., Baig, M. M. F. A., Ihsan, A. U., Shumzaid, M., Kakar, M. U., Mehmood Khan, T., Akabar, M., et al. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.01.192 · Cited by 508
Metadata
- Authors
- Markovsky, E., Baabur-Cohen, H., Eldar-Boock, A., Omer, L., Tiram, G., Ferber, S., Ofek, P., Polyak, D., Scomparin, A., & Satchi-Fainaro, R.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2012-07
- Volume
- 161
- Issue
- 2
- Pages
- 446-460
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2125424530
- Cited by
- 313
- References
- 171
- FWCI
- 7.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.